Matteo Trucco, MD

• National Pediatric Cancer Foundation (NPCF) Sunshine Project Consortium (Co-Chair and Protocol Committee member) 
• Make It Better (MIB) Agents (Member Board of Directors, Scientific Advisory Board Chair, FACTOR Conference Scientific Co-Chair)

• Cleveland Clinic Office of Professional Staff Affairs Professional Staff Mentoring Circles Program 2021
• Case Western Reserve University School of Medicine REFRAME program 2025
• Baylor College of Medicine Certificate of Added Qualifications in Clinical Investigations 2015
• ASCO/AARC Methods in Clinical Cancer Research Workshop 2013

• Benjamin and Mary Siddons Measey Foundation Merit Scholarship, 2003, Temple University School of Medicine
• Alpha Omega Alpha Honor Medical Society, 2005, Temple University School of Medicine
• Waldo E. Nelson M.D. Pediatric Award, 2006, Temple University School of Medicine
• Award of Excellence in Patient Care, 2006, 2007, Rainbow Babies and Children's Hospital
• Pediatric Practice Excellence Award,2007, Rainbow Babies and Children's Hospital
• Rainbow Ambulatory Pediatrics (RAP) Clinic Award, 2008, Rainbow Babies and Children's Hospital
• Rainbow Chief Award, 2008, Rainbow Babies and Children's Hospital
• Senior Day Award, 2009, Rainbow Babies and Children's Hospital
• Outstanding Teaching, 2018, University of Miami - Miller School of Medicine
• Researcher of the Year, 2019, Women's Cancer Association / University of Miami
• Best Fellowship Lecture, 2021, Cleveland Clinic Children's
• Cleveland Clinic Recognition Coin, 2024, Cleveland Clinic
• Cleveland’s Best Doctors, 2025, 2026, Cleveland Magazine

• Connective Tissue Oncology Society
• American Society of Clinical Oncology
• Sarcoma Alliance for Research through Collaboration
• Children’s Oncology Group (Site Principal Investigator)
• American Society of Pediatric Hematology-Oncology

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-04-27, Dr. Trucco has reported the financial relationships with the companies listed below.

Consulting and/or Speaking. Dr. Trucco receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Recordati SpA
• National Pediatric Cancer Foundation (NPCF)
• SERB Pharmaceuticals

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.